Amarin Corp PLC (STU:EH3A)
€ 0.442 -0.038 (-7.92%) Market Cap: 197.44 Mil Enterprise Value: -83.88 Mil PE Ratio: 0 PB Ratio: 0.37 GF Score: 38/100

Amarin Corporation PLC at H C Wainwright Global Investment Conference (Virtual) Transcript

Sep 12, 2022 / 01:00PM GMT
Release Date Price: €1.38 (+6.18%)
Andrew S. Fein
H.C. Wainwright & Co, LLC, Research Division - MD of Equity Research & Senior Healthcare Analyst

Hello, everyone. I'm Andrew Fein, one of the biotechnology analysts at H.C. Wainwright. Thank you for coming. Glad to be back in-person.

So the next company presenting will be Amarin, and presenting for the company will be its President and CEO, Karim Mikhail. Thank you.

Karim Mikhail
Amarin Corporation plc - President, CEO & Director

Thank you, Andrew. This is Karim Mikhail, President and CEO of Amarin. Today, my presentation may make some forward-looking statements. And of course, for all the list of risk factors, please do consult our SEC filing.

So at Amarin, we have a very focused growth strategy. Really, priority #1 is growing the VASCEPA business by stabilizing the U.S., launching successfully in Europe and expanding to international. And -- but also, we're also focusing, obviously, on managing the life cycle of VASCEPA. We have an incredible asset that we want to extend its life cycle and diversifying with BD

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot